Expanding morphological dimensions in neuropathology, from sequence biology to pathological sequences and clinical consequences

Neuropathology

Volumn 31, Issue 3, 2011, Pages 201-207

  Uchihara, Toshiki ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Neurite neuropathology; Sequence biology; Silver impregnations; Three dimension volumetry

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMINO ACID; NUCLEIC ACID; SILVER; TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; CELL INCLUSION; CLINICAL FEATURE; DEGENERATIVE DISEASE; HISTOPATHOLOGY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR DIAGNOSIS; MOLECULAR PATHOLOGY; MORPHOLOGY; NEURITE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SEQUENCE ANALYSIS; SHY DRAGER SYNDROME; SILVER IMPREGNATION; THREE DIMENSIONAL IMAGING; VOLUMETRY;

HUMANS; NERVOUS SYSTEM DISEASES; NEURITES; NEUROLOGY; PATHOLOGY, CLINICAL; STAINING AND LABELING;

EID: 79957562079     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01207.x     Document Type: Review

References (36)

1. Uchihara T, Paulus W. Research into neurodegenerative disease: an entangled web of mice and men [Editorial]. Acta Neuropathol 2008; 115: 1-4.
2. Alzheimer A. Über eingenartige Krankheitsfälle des spätern Alters. Zeitschr Gesam Neurol Psychiat 1911; 4: 356-385.
3. Bielschowsky M. Eine modifikation meines Silberimprägnationsverfahrens zur Darstellung der Neurofibrillen. Journal für Psychologie und Neurologie 1908; 12: 135-137.
4. Uchihara T, Tsuchiya K. Neuropathology of Pick body disease. In: Duyckaerts C, Litvan I, eds. Handbook of Clinical Neurology (Third Series) Dementia Volume 39. Amsterdam: Elsevier, 2008; 89: 415-430.
5. Oyanagi S. Ultrastructural Comparison between Pick Bodies and the Neurofibrillary Changes in Alzheimer's Disease and Progressive Supranuclear Palsy. In: Hirano A, Miyoshi K, eds. Neuropsychiatric disorders in the elderly. Tokyo: Igaku-Shoin, 1983; 118-126.
6. Probst A, Anderton BH, Ulrich J, Kohler R, Kahn J, Heitz PU. Pick's disease: an immunocytochemical study of neuronal changes. Monoclonal antibodies show that Pick bodies share antigenic determinants with neurofibrillary tangles and neurofilaments. Acta Neuropathol (Berl) 1983; 60: 175-182.
7. Delacourte A, Robitaille Y, Sergeant N etal. Specific pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996; 55: 159-168.
8. de Silva R, Lashley T, Gibb G etal. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 2003; 29: 288-302.
9. Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999; 9: 681-693.
10. Uchihara T, Mitani K, Mori H, Kondo H, Yamada M, Ikeda K. Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol 1994; 88: 379-383.
11. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971; 19: 1-8.
12. Campbell S, Switzer R, Martin T. Alzheimer's plaques and tangles: a controlled and enhanced silver staining method. Soc Neurosci Abstr 1987; 13: 678.
13. He Y, Duyckaerts C, Delaère P, Piette F, Hauw JJ. Alzheimer's lesions labelled by anti-ubiquitin antibodies: comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 1993; 19: 364-371.
14. Uchihara T, Shibuya K, Nakamura A, Yagishita S. Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer's disease - comparison between gallyas and campbell-switzer methods. Acta Neuropathol 2005; 109: 299-305.
15. Uchihara T, Tsuchiya K, Nakamura A, Akiyama H. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods. Acta Neuropathol 2005; 109: 483-489.
16. Uchihara T. Silver diagnosis in neuropathology: principles, practice and revised interpretation. Acta Neuropathol 2007; 113: 483-499.
17. Uchihara T, Nakamura A, Shibuya K, Yagishita S. Specific detection of pathological three-repeat tau after pretreatment with potassium permanganate and oxalic acid in PSP/CBD brains. Brain Pathol 2011; 21: 180-188.
18. Uchihara T, Nakamura A, Arai T, Ikeda K, Tsuchiya K. Microglial tau undergoes phosphorylation-independent modification after ischemia. Glia 2004; 45: 180-187.
19. Uchihara T, Tsuchiya K, Kondo H, Hayama T, Ikeda K. Widespread appearance of alz-50 immunoreactive neurons in the human brain with cerebral infarction. Stroke 1995; 26: 2145-2148.
20. Ichihara K, Uchihara T, Nakamura A, Suzuki Y, Mizutani T. Selective deposition of 4-repeat tau in cerebral infarcts. J Neuropathol Exp Neurol 2009; 68: 1029-1036.
21. Kasahata N, Miyazawa Y, Kamei T. Correspondence regarding "Selective deposition of 4-repeat tau in cerebral infarcts. J Neuropathol Exp Neurol 2009; 68: 1029-36. (Ref. 20)". J Neuropathol Exp Neurol 2010; 69: 321. [Letter to Eitor].
22. Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 2009; 118: 5-36.
23. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998; 95: 55-66.
24. Uchihara T, Tanaka J, Funata N, Arai K, Hattori T. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Acta Neuropathol 2003; 105: 103-108.
25. Uchihara T, Iwabuchi K, Funata N, Yagishita S. Attenuated nuclear shrinkage in neurons with nuclear aggregates - a morphometric study on pontine neurons of Machado-Joseph disease brains. Exp Neurol 2002; 178: 124-128.
26. Nagaoka U, Uchihara T, Iwabuchi K etal. Attenuated nuclear shrinkage in neurones with nuclear inclusions of sca1 brains. J Neurol Neurosurg Psychiatry 2003; 74: 597-601.
27. Koyano S, Iwabuchi K, Yagishita S, Kuroiwa Y, Uchihara T. Paradoxical absence of nuclear inclusion in cerebellar purkinje cells of hereditary ataxias linked to CAG expansion. J Neurol Neurosurg Psychiatry 2002; 73: 450-452.
28. Uyama N, Uchihara T, Mochizuki Y, Nakamura A, Takahashi R, Mizutani T. Selective nuclear shrinkage of oligodendrocytes lacking glial cytoplasmic inclusions in multiple system atrophy: a 3-dimensional volumetric study. J Neuropathol Exp Neurol 2009; 68: 1084-1091.
29. Uchihara T, Nakamura A, Mochizuki Y etal. Silver stainings distinguish lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods. Acta Neuropathol 2005; 110: 255-260.
30. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 1988; 75: 345-353.
31. Kanazawa T, Uchihara T, Takahashi A, Nakamura A, Orimo S, Mizusawa H. Three-layered structure shared between lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections. Brain Pathol 2008; 18: 415-422.
32. Orimo S, Uchihara T, Nakamura A etal. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008; 131: 642-650.
33. Matsuda W, Furuta T, Nakamura KC etal. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 2009; 29: 444-453.
34. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH. Parkinsonism-inducing neurotoxin, n-methyl-4-phenyl-1, 2, 3, 6 -tetrahydropyridine: uptake of the metabolite n-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 1985; 82: 2173-2177.
35. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. 123)i-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 189-194.
36. Toru S, Uchihara T, Takahashi M etal. Depletion or preservation of cardiac sympathetic nerve - an autopsy-verified contrast in two cases of Alzheimer's disease with or without Lewy bodies. Eur Neurol 2010; 64: 129-133.